The 21-gene assay and its impact on breast cancer treatment
Joseph Ragaz, MD, FRCPC
More>>

Cancer Transitions: a supportive care program for cancer survivors
Challenges and successes
Amanda Ward, PhD; Richard Doll, MSW, MSc; Svetlana Ristovski-Slijepcevic, PhD;
Arminee Kazanjian, DrSoc; Mitch Golant, PhD
More>>

We welcome your letters and suggestions for future articles.

Please address correspondence to Devon Phillips, Managing Editor, at editors@oncologyex.com

Reports from ASH and ASCO-GI

LYMPHOMA: first-line treatment for advanced disease
Stephen Couban, MD, FRCPC

MULTIPLE MYELOMA: outcome improvements using combination
regimens in older patients
Shamin Wadiwalla, MD; Tony Reiman, MD, SM, FRCPC

COLON CANCER: impact of KRAS biomarker in therapy selection
Ralph Wong, MD, FRCPC

COLON CANCER: recent advances in adjuvant therapy
Timothy Asmis, MD, FRCPC

PANCREATIC CANCER: novel screening tools
Sharlene Gill, MD, MPH, FACP, FRCPC

PSYCHOSOCIAL CARE: evidence for end-of-life planning
Ester Green RN, MSc(T); Bejoy Thomas, MPhil, PhD

More>>